<DOC>
	<DOCNO>NCT02864121</DOCNO>
	<brief_summary>High-risk human papillomavirus ( HR-HPV ) involve cervical cancer development . Integration HR-HPV DNA cellular genome consider major event cervical cancer development . The aim study validate integration HPV-HR appropriate biomarker severity precancerous lesion progression cervical lesion towards cervical cancer . HR-HPV integration status analyze Molecular Combing technology , allow direct high-resolution visualization integration high-risk HPV genome .</brief_summary>
	<brief_title>Oncogenous HPV DNA Integration ( Intégration De l'ADN Des HPV Oncogènes )</brief_title>
	<detailed_description />
	<criteria>woman age 25 65 year consult gynecologicalobstetrical service one investigator center colposcopy reflex abnormal cytology date less 6 month 1 month signature inform consent affiliate Social Security woman vaccinate HPV woman receive treatment cervical pathology follow normal woman know positive HIV test woman suffer chronic pathology generate immunosuppression Women currently treat immunosuppressor Women treat corticoid currently date less 6 month protect law pregnant</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>High-risk human papillomavirus</keyword>
	<keyword>Integration HR-HPV DNA</keyword>
	<keyword>biomarker severity</keyword>
	<keyword>biomarker evolution</keyword>
</DOC>